It has been proposed that Hsp104 has the therapeutic potential to protect higher eukaryotes against the toxic effects of neurodegenerative disease substrates, such as TDP-43, FUS, and α-synuclein [52,53,54]. Here, TARDBP is linked to neurodegenerative disease.